Skip to content

Talphera, Inc. TLPH Operating Income

Operating Income at other companies

Baxter International logo
Baxter InternationalBAX
$66M+13.8%
AMP
Amphastar PharmaceuticalsAMPH
$13.63M-63.5%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$34.2M+59.2%
Royalty Pharma logo
Royalty PharmaRPRX
$563.04M+5.4%
PTH
Pelthos Therapeutics Inc.PTHS
-$13.09M-614%
XOMA Corporation logo
XOMA CorporationXOMA
-$480K-108%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+493%
P/S53,456.6×+53,123×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s operating income?
Talphera, Inc. (TLPH) reported operating income of -$3.95M in Q1 2026.
How has Talphera, Inc.'s operating income changed year-over-year?
Talphera, Inc.'s operating income decreased by 35.4% year-over-year, from -$2.92M to -$3.95M.
What is the long-term trend for Talphera, Inc.'s operating income?
Over 3 years (2021 to 2025), Talphera, Inc.'s operating income has grown at a -27.9% compound annual growth rate (CAGR), from -$35.97M to -$13.48M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.